Personalized treatment for normal and high-risk patients using immunotherapy and transplant with Dr. Ivan Borrello, MD, PhD, Johns Hopkins

Dr. Ivan Borrello, MD, PhD of Johns Hopkins shares his work to create a patient-specific immunotherapy using enhanced T cells from the patient's own bone marrow

Posted by

HealthTree

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra

In our fifth MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Bruno Paiva describes his study of chemo-resistant myeloma cells

Posted by

HealthTree

Overcoming Deletion 17p Using a Specifically Targeted Therapy with Dr. Robert Orlowski, MD, PhD, MD Anderson

In our fourth MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Robert Orlowski of the MD Anderson Cancer Center teaches us

Posted by

HealthTree

Remarkable approach for highly aggressive myeloma and PCL using safer allo transplant techniques in combination with immunotherapies. Dr. Guenther Koehne, MD, PhD, MSKCC

In our second MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Guenther Koehne explains a truly extraordinary approach for

Posted by

HealthTree

Hot immunotherapy work using CAR T cells for a common myeloma target with Dr. Craig Hofmeister, MD, OSU

In our first MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Craig Hofmeister shares his work to use the hot-topic

Posted by

HealthTree